Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CTT Pharmaceutical HoldingsCTTH -0.13% Current Ratio is 0.48 as of Dec. 2025, which is at its 10-year median of 0.48. The stock has 4 warning signs investors should review. Among 1,000 Drug Manufacturers companies, CTT Pharmaceutical Holdings ranks worse than 93.8% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. CTT Pharmaceutical Holdings's current ratio for the quarter that ended in Dec. 2025 was 0.48.
CTT Pharmaceutical Holdings has a current ratio of 0.48. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If CTT Pharmaceutical Holdings has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for CTT Pharmaceutical Holdings's Current Ratio or its related term are showing as below:
CTTH'
s Current Ratio Range Over the Past 10 Years
Min: 0.48 Med: 0.48 Max: 0.48
Current: 0.48
During the past 13 years, CTT Pharmaceutical Holdings's highest Current Ratio was 0.48. The lowest was 0.48. And the median was 0.48.
CTTH's Current Ratio is ranked worse than 93.8% of 1000
companies
in the Drug Manufacturers industry
Industry Median: 2
vs CTTH: 0.48
CTT Pharmaceutical Holdings (OTCPK:CTTH) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
CTT Pharmaceutical Holdings Current Ratio Related Terms
CTT Pharmaceutical Holdings Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CTTH vs BUDZ, SBFM, PRFX: Current Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, CTT Pharmaceutical Holdings's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CTT Pharmaceutical Holdings Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CTT Pharmaceutical Holdings's Current Ratio distribution charts can be found below:
* The bar in red indicates where CTT Pharmaceutical Holdings's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CTT Pharmaceutical Holdings (CTTH) has a Current Ratio of 0.48 as of Dec. 2025. This is near median its historical median of 0.48. Over the past decade, CTT Pharmaceutical Holdings' Current Ratio has ranged from 0.48 to 0.48. According to the industry distribution chart, CTT Pharmaceutical Holdings ranks #938 out of 1000 companies in the Drug Manufacturers industry, placing it in the top 93.8%.
Is CTT Pharmaceutical Holdings' Current Ratio too high?
CTT Pharmaceutical Holdings' current Current Ratio of 0.48 is near median its 10-year median of 0.48. Over the past 10 years, this metric has ranged from a low of 0.48 to a high of 0.48. The Drug Manufacturers industry median Current Ratio is 2.00. CTT Pharmaceutical Holdings' value of 0.48 is 76% below this industry median. Based on the distribution chart, CTT Pharmaceutical Holdings ranks #938 out of 1000 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does CTT Pharmaceutical Holdings' Current Ratio compare to BUDZ and SBFM?
According to the Drug Manufacturers industry distribution chart, CTT Pharmaceutical Holdings ranks #938 out of 1000 companies for Current Ratio. This places CTT Pharmaceutical Holdings in the lower half of its industry. The industry median Current Ratio is 2.00. CTT Pharmaceutical Holdings' value of 0.48 is 76% below this benchmark. Historically, CTT Pharmaceutical Holdings' own Current Ratio has ranged from 0.48 to 0.48 over the past decade. While the company's 10-year median is 0.48 vs. the industry median of 2.00, CTT Pharmaceutical Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 1,000 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CTT Pharmaceutical Holdings's current Current Ratio of 0.48 is 76% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CTT Pharmaceutical Holdings's current Current Ratio is 0.48, which is near median its own 10-year median of 0.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CTT Pharmaceutical Holdings stock overvalued right now?
CTT Pharmaceutical Holdings (CTTH) has a current Current Ratio of 0.48. The current Current Ratio is 0.48, which is near median its 10-year median of 0.48 and 76% below the Drug Manufacturers industry median of 2.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For CTT Pharmaceutical Holdings (CTTH), the current Current Ratio is 0.48 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CTT Pharmaceutical Holdings Inc specializes in drug delivery systems technology within the pharmaceutical industry. Its focus is on fast-dissolving drug delivery systems through the development of oral delivery thin wafers. The company's technology platform includes the development of oral delivery thin wafers to deliver treatment as an alternative to smoking and ingestion. This technology platform target both the human and veterinarian(pet) markets for treatment of many diseases. The Company believes that its technology will be one of the first to gain use in majorly markets such as pain management and smoking cessation. The Oral Thin Film formulation is protected by patents in the USA, Canada, Europe and many other countries across the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CTTH has been successfully added to your 
